1 available, 1 recruiting. .
Follow Actinic Prurigo: new trials by email Literature Review of Actinic Prurigo trials Research Report on Actinic Prurigo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-centred Clinico-genetic Study of Actinic Prurigo in Thailand Targeted long-read HLA sequencing, RNA extraction, Full Skin examination - Actinic Prurigo | Recruiting | Chulalongkorn University | 47 | 2025-03-30 | 2026-05-12 | |
| Compassionate Use or Expanded Access of Dupilumab Dupilumab - Type 2 Inflammatory Disorders | Available | Regeneron Pharmaceuticals | 2026-09-01 |
Chronic Urticaria (1) · Eosinophilic Esophagitis (1) · Hypersensitivity (1) · Pemphigoid, Benign Mucous Membrane (1) · Pemphigus (1) · Pemphigus, Benign Familial (1)
Autoimmune Diseases (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Conjunctival Diseases (1) · Digestive System Diseases (1) · Disease Attributes (1) · Eosinophilia (1) · Esophageal Diseases (1) · Esophagitis (1) · Eye Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
dupilumab (1)
Chulalongkorn University (1) · Regeneron Pharmaceuticals (1)
Thailand (1)